1. Hu YX, Chen AL , Zheng XC, Lu J, He HL, Yang J, Zhang Y, Sui PP, Yang JY, He FH, Wang Y, Xiao PF, Liu X, Zhou YM, Pei DQ, Cheng C, Ribeiro R C*, Hu SY* and Wang QF*. Ecological principle meets cancer treatment: treating children with acute myeloid leukemia with low-dose chemotherapy. National Science Review. 6: 469–479, 2019
2. Yang XJ, Lu YD, He FH, Hou FX, Xing CH*, Xu PY*, Wang QF*. Benzene metabolite hydroquinone promotes DNA homologous recombination repair via the NF-Κb pathway. Carcinogenesis. 2019 Feb 16. pii: bgy157. doi: 10.1093/carcin/bgy157. [Epub ahead of print]
3. Zhang P , He FH, Bai J, Yamamoto S, Chen S, Zhang L, Sheng MY, Zhang L, Guo Y, Man N, Yang H, Wang SY, Cheng T, Nimer SD, Zhou Y, Xu MJ*, Wang QF* and Yang FC*. Chromatin regulator Asxl1 loss and Nf1 haploinsufficiency cooperate to accelerate myeloid malignancy. J Clin Invest. 128(12):5383-5398,2018
4. Yang XJ, Lu B, Sun XQ, Han CJ, Fu CL, Xu KL, Wang M, Li DJ, Chen ZC, Opal P, Wen Q, Crispino JD, Wang QF*, Huang Z*. ANP32A regulates histone H3 acetylation and promotes leukemogenesis. Leukemia. 32(7):1587-1597,2018
5. Bu JC, Chen AL, Yan XM, He FH, Dong YZ, Zhou YL, He JL, Zhan D, Lin PP, Hayashi Y, Sun YL, Zhang Y, Xiao ZJ, Grimes HL, Wang QF* and Huang G*. SETD2 mediated crosstalk between H3K36me3 and H3K79me2 in MLL-rearranged leukemia. Leukemia.32(4):890-899,2018
6. Li YY, Jin C, Bai H, Gao YX, Sun S, Chen L, Qin L, Liu PP, Cheng LZ*, Wang QF*. Human NOTCH4 is a key target of RUNX1 in megakaryocytic differentiation. Blood. 131(2):191-201,2018
7. Huang L, Liu D, Wang N, Ling SP, Tang YT, Wu J, Hao LT, Luo H, Hu XL, Sheng LS, Zhu LJ, Wang D, Luo Y, Shang Z, Xiao M, Mao X, Zhou KG, Cao LH, Dong LL, Zheng XC, Sui PP, He JL, Mo SL, Yan J, Ao QL, Qiu LG, Zhou HS, Liu QF, Zhang HY, Li JY, Jin J, Fu L, Zhao WL, Chen JP, Du X, Qing GL, Liu HD, Liu X, Huang G, Ma D, Zhou JF*, Wang QF*. Integrated Genomic Analysis Identifies Deregulated JAK/STAT-MYC-Biosynthesis Axis in Aggressive NK-cell Leukemia.Cell Research. 28(2):172-186,2018
8. Zhan D, Zhang YC, Xiao PF, Zheng XC, Ruan M, Zhang JL, Chen AL, Zou Y, Chen YM, Huang G, Hu SY, Wang QF*, Zhu XF*. Whole exome sequencing identifies novel mutations of epigenetic regulators in chemorefractory pediatric acute myeloid leukemia. Leukemia Research. 65:20-24,2018
9. Zheng M, Lin FL, Hou FX, Li GL, Zhu CY, Xu PY, Xing CH*, Wang QF*. Association between Promoter Methylation of Gene ERCC3 and Benzene Hematotoxicity. Int. J. Environ. Res. Public Health. 14(8):921,2017
10. Li JP, He FH, Zhang P, Chen S, Shi H, Sun YL, Guo Y, Yang H, Man N, Greenblatt S, Li ZM, Guo ZY, Zhou Y, Wang L, Morey L, Williams S, Chen X, Wang QT, Nimer S, Yu P, Wang QF*, Xu MJ* and Yang FC*. Loss of Asxl2 leads to myeloid malignancies in mice. Nature Communications. 2017 Jun 8;8:15456. doi: 10.1038/ncomms15456
11. Yu RX, Liu D, Yang Y, Han YY, Li LR, Zheng LY, Winges DM, Wang J, Zhang Y, Wang QF* and Wang Q*. Expression profiling-based clustering of healthy subjects recapitulates classifications defined by clinical observation in Chinese medicine. Journal of Genetics and Genomics. 44(4):191-7,2017
12. Zhang P, Xing CH, Rhodes SD, He YZ, Deng K, Li ZM, He FH, Zhu CY, Nguyen L, Zhou Y, Chen S, Mohammad K S, Guise TA, Abdel-Wahab O, Xu MJ, Wang QF* and Yang FC*. Loss of asxl1 alters self-renewal and cell fate of bone marrow stromal cell, leading to Bohring-Opitz-like syndrome in Mice. Stem Cell Reports. 6(6):914-925,2016
13. Kang L*, Wu J, Tao Y, Li HL, Liu XL, Gao SR* and Wang QF*. Cell type-specific expression profile and signaling requirements in early hematopoietic reprogramming. Stem Cells Dev. 24(12),1483-1492,2015
14. Chen AL, Yang JY, Hu SY* and Wang QF*. The priming inducton regimen of HAG as a low dose strategy in AML clonal evolution. Sci China Life Sci.58(12),1302-1305,2015
15. Wang QF* and Cheng T*. Evidences for mutations in the histone modifying gene SETD2 as critical drivers in leukemia development. Sci China Life Sci. 57(9):944-946,2014
16. Cai J, Miao XX, Li YY, Smith C, Tsang K, Cheng LZ* and Wang QF*. Whole-genome sequencing identifies genetic variances in culture-expanded human mesenchymal stem cells. Stem Cell Reports. 3(2):227-233,2014
17. Zhu XF, He FH, Zeng HM, Ling SP, Chen AL, Wang YQ, Yan XM, Wei W, Pang YK, Cheng H, Hua CL, Zhang Y, Yang XJ, Lu X, Cao LH , Hao LT, Dong LL, Zou W, Wu J, Li X, Zheng S, Yan J, Zhou J, Zhang LX , Mi SL, Wang XJ, Zhang L, Zou Y, Chen YM, Geng Z, Zhou JF, Wang JM, Liu X, Wang JX, Yuan WP, Huang G*, Cheng T* and Wang QF*. Identification of functional cooperative mutations of SETD2 in human acute leukemia. Nature Genetics. 46(3): 287-293,2014
18. Zhou J, Wu J, Li B, Liu D, Yu J, Yan XM, Zheng S, Wang JG, Zhang LX, Zhang L, He FH, Li Q, Chen AL, Zhang Y, Zhao XH, Guan YH, Zhao XH, Yan J, Ni J, Nobrega M, L?wenberg B, Delwel R, Valk P J, Kumar A, Xie L, Tenen DG, Huang G* and Wang QF*. PU.1 is essential for MLL leukemia partially via crosstalk with the MEIS/HOX pathway. Leukemia. 28(7): 1436-1448, 2014
19. Wang QF*, Li YJ, Dong JF, Li B, KaberleinJJ, Zhang L, Arimura FE, Luo RT, Ni J, He FH, Wu J, Mattison R, Zhou J, Wang CZ, Prabhakar S, Nobrega M A and Thirman M J*. Regulation of MEIS1 by distal enhancer elements in acute leukemia.Leukemia.28(1):138-146,2014
20. Wang QF, Wu G, Mi SL, He FH, Wu J, Dong JF, Luo RT, Mattison R, Kaberlein JJ, Prabhakar S, Ji HK and Thirman MJ. MLL fusion proteins preferentially regulate a subset of wild type MLL target genes in the leukemic genome. Blood.117(25):6895-6905,2011
21. Xing C*, Wang QF*, Li B, Tian H, Ni Y, Yin S and Li G. Methylation and expression analysis of tumor suppressor genes p15 and p16 in benzene poisoning. Chemico-Biological Interactions. 184:306-309,2010
22. Wang QF*, Prabhakar S, Chanan S, Cheng JF, Rubin EM and Boffelli D*. Detection of weakly conserved ancestral mammalian regulatory sequences by primate comparisons. Genome Biology. 8(1):R1, 2007
23. Wang QF*, Prabhakar S*, Wang Q, Moses A, Chanan S, Brown M, Eisen M, Cheng JF, Rubin E and Boffelli D. Primate-specific evolution of an LDLR enhancer. Genome Biology.7(8):R68, 2006 (共同第一作者)
24. Wang QF, Liu X, O’nell J, Peng Z, Krauss R, Rainwater DL, Vandeberg JL, Rubin EM, Cheng J F and Pennacchio LA. Haplotypes in the APOA1-C3-A4-A5 Gene Cluster affect Plasma Lipids in both Humans and Baboons. Human Molecular Genetics.13(10):1049-1056,2004
25. Wang QF, Cleaves R, Kummalue T, Nerlov C and Friedman A D. Cell cycle inhibition mediated by the outer surface of the C/EBPalpha basic region is required but not sufficient for granulopoiesis. Oncogene. 22(17):2548-2557,2003
26. Wang QF and Friedman A D. C/EBPs are required for granulopoiesis independent of their induction of the granulocyte-colony stimulating factor receptor. Blood. 99(8):2776-2785, 2002
27. Wang QF, Lauring J, and Schlissel M S. c-Myb binds to a sequence in the proximal region of the RAG-2 promoter and is essential for promoter activity in T-lineage cells.Molecular and Cellular Biology.20:9203-9211,2000
|